John F. Forbes

TL;DR: Patients and clinicians report difficulties with the process of informed consent to clinical trials and audiotape audits show that critical information is often omitted or poorly presented, and decision aids (DAs) may assist in improving consent.

TL;DR: This is the first study to look at the implementation of computed tomography in the patient care pathway that is outcome focused and will have major implications for the management of patients with cardiovascular disease.

TL;DR: There is continued evidence that patients randomly assigned to receive goserelin + chemotherapy were not only more likely to avoid premature menopause, but were also morelikely to become pregnant without adverse effect on disease-related outcomes.

TL;DR: This trial, although small, offers no evidence that AC chemotherapy provides additional disease control for premenopausal patients with lower-risk node-positive endocrine-responsive breast cancer who receive adequate adjuvant endocrine therapy.

TL;DR: Age-adjusted risk profiles that consider patient-reported outcomes enable patients to adapt to their disease and treatment, such as considering the trade-offs between delayed endocrine symptoms, but higher risk of permanent menopause with chemotherapy, and immediate but reversible endocrine Symptoms with goserelin, in younger premenopausal patients.